// App-Quantinova.ai

916-07 : PARADIGM SHIFT IN THE TREATMENT OF PULMONARY EMBOLISM: SAFE DOSE THROMBOLYSIS PLUS RIVAROXABAN

Researchers

Presenter

  • Mohsen Sharifi

Principal Investigators

  • Wilbur Freeman

  • Curt Bay

  • Mirali Sharifi

  • Frederic Schwartz

  • Laura Skrocki

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pulmonary arterial hypertension

  • Venous thrombosis

  • Pulmonary embolism

  • Hypertension

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • rivaroxaban

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved